Inventor · disambiguated record
Thinnayam N. Krishnamurthy
Also filed as: KRISHNAMURTHY THINNAYAM N · KRISHNAMURTHY THINNAYAM NAGANATHAN
18 granted patents·1 pending application·1,205 citations·filing 1991–2017
96Inventor score
Files withEURO CELTIQUE SA8PURDUE PHARMA4RHODES PHARMACEUTICALS LP4DANAGHER HELEN KATHLEEN1KRISHNAMURTHY THINNAYAM N1
Top patents by PatentIndex Score
19 records- 0197US6419960B1Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrationsEURO CELTIQUE SA·Filed 1999·Granted Jul 16, 2002·183 cites·18 claims
- 0297US5811126AControlled release matrix for pharmaceuticalsEURO CELTIQUE SA·Filed 1995·Granted Sep 22, 1998·299 cites·26 claims
- 0397US5215758AControlled release matrix suppository for pharmaceuticalsEURO CELTIQUE SA·Filed 1991·Granted Jun 1, 1993·279 cites·13 claims
- 0495US5508043AControlled release matrix for pharmaceuticalsEURO CELTIQUE SA·Filed 1995·Granted Apr 16, 1996·168 cites·12 claims
- 0594US9801823B2Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrationsPURDUE PHARMA·Filed 2015·Granted Oct 31, 2017·13 cites·12 claims
- 0694US7438930B2Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrationsPURDUE PHARMA·Filed 2007·Granted Oct 21, 2008·21 cites·11 claims
- 0794US7083808B2Controlled/modified release oral methylphenidate formulationsEURO CELTIQUE SA·Filed 2003·Granted Aug 1, 2006·84 cites·10 claims
- 0893US9066869B2Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrationsPURDUE PHARMA·Filed 2013·Granted Jun 30, 2015·13 cites·20 claims
- 0990US8580310B2Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrationsKRISHNAMURTHY THINNAYAM N·Filed 2008·Granted Nov 12, 2013·16 cites·7 claims
- 1090US7247318B2Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrationsPURDUE PHARMA·Filed 2002·Granted Jul 24, 2007·24 cites·12 claims
- 1190US6673367B1Controlled/modified release oral methylphenidate formulationsEURO CELTIQUE SA·Filed 1999·Granted Jan 6, 2004·102 cites·5 claims
- 1279US10463624B2Controlled release formulationsRHODES PHARMACEUTICALS LP·Filed 2017·Granted Nov 5, 2019·1 cites·32 claims
- 1370US9814710B2Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndromeEURO CELTIQUE SA·Filed 2014·Granted Nov 14, 2017·1 cites·11 claims
- 1467US10039719B2Methods of treating attention deficit hyperactivity disorderRHODES PHARMACEUTICALS LP·Filed 2017·Granted Aug 7, 2018·0 cites·32 claims
- 1565US10022330B2Methods of preparing oral controlled release formulationsRHODES PHARMACEUTICALS LP·Filed 2016·Granted Jul 17, 2018·0 cites·8 claims
- 1664US9949931B2Methods of treating attention deficit hyperactivity disorderRHODES PHARMACEUTICALS LP·Filed 2016·Granted Apr 24, 2018·0 cites·23 claims
- 1762US9700508B2Pharmaceutical compositions comprising hydromorphone and naloxoneDANAGHER HELEN KATHLEEN·Filed 2011·Granted Jul 11, 2017·1 cites·48 claims
- 1853US10258616B2Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndromeEURO CELTIQUE SA·Filed 2017·Granted Apr 16, 2019·0 cites·18 claims
- 1936US2012021057A1Once-daily oral ir/cr pramipexole formulationKRISHNAMURTHY THINNAYAM NAGANATHAN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thinnayam N. Krishnamurthy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →